SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Under the Securities Exchange Act of 1934
BIOSAFE INTERNATIONAL, INC.
- -----------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
- -----------------------------------------------------------------------------
(Title of Class of Securities)
090932 10 4
- ------------------------------------------------------------------------------
(CUSIP Number)
Richard Rosen, 55 Cambridge Street, Burlington, MA 01803, (617) 497-1200
- ------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
May 2, 1996
- ------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the person has previously filed a statement on Schedule 13G to report the
acquisition which is the subject of this Schedule 3D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above
Persons Richard Rosen ###-##-####
2) Check the Appropriate Box if a Member of a Group
(a)
(b)
3) SEC Use Only
4) Source of Funds PF
5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e)
6) Citizenship or Place of Organization U.S.
Number of 7) Sole Voting Power 1,047,000
Shares Bene-
ficially 8) Shared Voting Power 0
Owned by
Each Report- 9) Sole Dispositive Power 1,047,000
ing Person
With 10) Shared Dispositive Power 0
11) Aggregate Amount Beneficially Owned by
Each Report Person 1,047,000
12) Check if the Aggregate Amount in Row (11)
Excludes Certain Shares
13) Percent of Class Represented by Amount
in Row (11) 6.4%
14) Type of Reporting Person IN
1. Security and Issuer.
The title of the class of equity securities to which this statement relates is
common stock, $0.001 par value (the "Common Stock"), issued by BioSafe
International, Inc., a Nevada corporation (the "Corporation"). The principal
offices of the Corporation are located at 10 Fawcett Street, Cambridge,
Massachusetts 02138.
2. Identity and Background.
This statement is filed by Richard Rosen. Mr. Rosen's principal business is
investing, and Mr. Rosen's business address is 55 Cambridge Street,
Burlington, MA 01803.
During the last five years, Richard Rosen has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors), nor been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction, the result of which was to subject it to a judgment, decree or
final order enjoining further violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
3. Source and Amount of Funds of Other Consideration.
This Schedule 13D is being filed to report 1,047,000 shares of the
Corporation's Common Stock which Richard Rosen purchased at various times form
1990 through 1994 when the Corporation was a privately held corporation.
4. Purpose of Transaction.
Richard Rosen acquired the 1,047,000 shares of Common Stock as a result of
purchases made from 1990 to 1994. Mr. Rosen originally held the shares for
investment purposes only. However, due to recent mismanagement and a proposal
by the Corporation to the shareholders of the Corporation to change the
domicile of the Corporation from Nevada to Delaware and to adopt certain anti-
takeover provisions as a result of this reincorporation, Mr. Rosen now intends
to take certain steps to oppose the current management of the Corporation,
including filing a competing proxy solicitation to oppose such
reincorporation. Any other steps to oppose management have yet to be
specifically determined. In addition, Mr. Rosen is currently involved in a
legal dispute with the Corporation concerning Mr. Rosen's personal
responsibility for certain actions taken while Mr. Rosen was an officer of the
Corporation.
Dr. Rosen is now considering certain additional actions with respect to his
investment, including, but not limited to, any or all of the following
actions: selling all or a portion of his shares of the Company's common stock;
accumulating additional shares of the Company's common stock; making an offer
to purchase additional shares of the Company's common stock; seeking
representation on and/or control of the Company's Board of Directors by
proposing nominees for election to the Board of Directors at the Company's
annual meeting of otherwise; and, seeking to replace current management either
through negotiation or otherwise.
5. Interest in Securities of the Issuer.
Richard Rosen holds 1,047,000 shares of Common Stock. Mr. Rosen believes that
the foregoing shares represent approximately 6.4% of the approximately
16,400,000 shares of Common Stock issued and outstanding as of the date
hereof. Mr. Rosen has the sole voting and investment power with respect to
all such shares held in its name. Mr. Rosen has not engaged in any
transaction in shares of the Common Stock during the past 60 days.
6. Contracts, Arrangements, Understandings or Relationships with Respect to
securities of the Issuer.
None.
7. Materials to be Filed as Exhibits.
None.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct.
Dated: May 2, 1997 /s/ Dr. Richard Rosen
------------------------
